Compounds > deoxypyridinoline
Page last updated: 2024-08-26

deoxypyridinoline and risedronic acid

deoxypyridinoline has been researched along with risedronic acid in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's10 (71.43)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bekker, PJ; Charles, P; Digennaro, J; Johnston, CC; Mortensen, L1
Digennaro, J; Fall, P; Raisz, L; Sacco-Gibson, N; Shoukri, K; Smith, JA; Trahiotis, M1
Fukunaga, M; Inoue, T; Kishimoto, H; Kushida, K; Minaguchi, H; Morii, H; Morita, R; Ohashi, Y; Orimo, H; Shiraki, M; Taketani, Y; Yamamoto, K1
Callaci, JJ; Frost, N; Juknelis, D; Patwardhan, A; Sartori, M; Wezeman, FH1
Barton, I; Grauer, A; Naganathan, V; Seibel, MJ1
Ikeda, S; Ito, M; Nakamura, T; Otomo, H; Phipps, RJ; Sakai, A; Tanaka, S1
Fukunaga, M; Inoue, T; Itabashi, A; Kaneda, K; Kishimoto, H; Kushida, K; Morii, H; Nawata, H; Ohashi, Y; Orimo, H; Shiraki, M; Yamamoto, K1
Sarioglu, M; Taneli, F; Tikiz, C; Tuzun, C; Unlu, Z; Uyanik, BS1
D'Emden, M; Ebeling, PR; Ernst, TF; Graham, JJ; Hooper, MJ; Nicholson, GC; Roberts, AP; Wenderoth, D1
Honda, Y; Iwamoto, J; Sato, Y1
Allen, MR; Burr, DB; Delmas, PD; Gineyts, E; Leeming, DJ1
Izumi, K; Kitagawa, Y; Koh, E; Mizokami, A; Namiki, M; Narimoto, K; Sugimoto, K1
Gulseren, A; Peyman, B; Pinar, A1
Liel, Y; Plakht, Y; Tailakh, MA1

Trials

10 trial(s) available for deoxypyridinoline and risedronic acid

ArticleYear
Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:2

    Topics: Adult; Alkaline Phosphatase; Amino Acids; Bone Density; Calcium Channel Blockers; Creatinine; Double-Blind Method; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Risedronic Acid; Time Factors

1998
Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2000, Volume: 11, Issue:7

    Topics: Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Calcium Channel Blockers; Cohort Studies; Collagen; Collagen Type I; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Peptides; Postmenopause; Procollagen; Risedronic Acid

2000
A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group).
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2003, Volume: 14, Issue:3

    Topics: Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Etidronic Acid; Female; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Osteoporosis, Postmenopausal; Risedronic Acid; Treatment Outcome

2003
Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:2

    Topics: Aged; Amino Acids; Bone Density; Bone Resorption; Etidronic Acid; Female; Humans; Incidence; Osteoporosis; Placebos; Postmenopause; Risedronic Acid; Spinal Fractures

2004
A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.
    Journal of bone and mineral metabolism, 2004, Volume: 22, Issue:5

    Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Body Height; Bone and Bones; Collagen; Collagen Type I; Etidronic Acid; Female; Humans; Incidence; Japan; Osteoporosis, Postmenopausal; Peptides; Quality of Life; Risedronic Acid; Spinal Fractures; Surveys and Questionnaires

2004
Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
    Rheumatology international, 2006, Volume: 26, Issue:3

    Topics: Aged; Alendronate; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcium; Creatinine; Double-Blind Method; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Risedronic Acid

2006
Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3

    Topics: Absorptiometry, Photon; Adult; Amino Acids; Biomarkers; Bone Density Conservation Agents; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Risedronic Acid; Treatment Outcome

2005
Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
    Neurology, 2007, Mar-20, Volume: 68, Issue:12

    Topics: Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Resorption; Double-Blind Method; Ergocalciferols; Etidronic Acid; Hip Fractures; Humans; Hyperparathyroidism; Male; Osteoporosis; Parkinson Disease; Placebo Effect; Prospective Studies; Risedronic Acid; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin D Deficiency

2007
Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study.
    Prostate cancer and prostatic diseases, 2011, Volume: 14, Issue:3

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Androgen Antagonists; Antineoplastic Agents; Biomarkers; Bone Density; Bone Density Conservation Agents; Etidronic Acid; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Lost to Follow-Up; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Radiography; Risedronic Acid

2011
Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin.
    Panminerva medica, 2011, Volume: 53, Issue:2

    Topics: Aged; Amino Acids; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen Type I; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoprotegerin; Postmenopause; Risedronic Acid; Vitamin D

2011

Other Studies

4 other study(ies) available for deoxypyridinoline and risedronic acid

ArticleYear
The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.
    Alcoholism, clinical and experimental research, 2004, Volume: 28, Issue:1

    Topics: Amino Acids; Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Diphosphonates; Ethanol; Etidronic Acid; Male; Rats; Rats, Sprague-Dawley; Risedronic Acid

2004
Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Journal of bone and mineral metabolism, 2004, Volume: 22, Issue:5

    Topics: Absorptiometry, Photon; Amino Acids; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Matrix; Etidronic Acid; Female; Femur; Lumbar Vertebrae; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Tomography, X-Ray Computed; Vitamin K 2

2004
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:3

    Topics: Alendronate; Amino Acids; Animals; Arginine; Bone Density Conservation Agents; Bone Remodeling; Collagen; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Etidronic Acid; Female; Lumbar Vertebrae; Lysine; Raloxifene Hydrochloride; Risedronic Acid

2008
BONE TURNOVER IN OSTEOPOROTIC WOMEN DURING LONG-TERM ORAL BISPHOSPHONATES TREATMENT: IMPLICATIONS FOR TREATMENT FAILURE AND "DRUG HOLIDAY" IN THE REAL WORLD.
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:7

    Topics: Administration, Intravenous; Administration, Oral; Aged; Alendronate; Amino Acids; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Deprescriptions; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Risedronic Acid; Time Factors; Treatment Failure; Zoledronic Acid

2017